Galantamine
- Product NDC
- 0591-3496
- 11-digit product format
- 005913496
- Labeler code
- 0591
- Product ID
- 0591-3496_f5a193b9-78b1-4bfe-97b1-a98969f0f303
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Galantamine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA079028
- Marketing category
- ANDA
- Marketing start
- 2008-12-15
- Marketing end
- 0000-00-00
- Substance
- GALANTAMINE HYDROBROMIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-3496-30 | 00591349630 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0591-3496-30) | 2008-12-16 | 0000-00-00 | No | No | Current |